NCT03144583View on ClinicalTrials.gov

Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

September 13, 2022

Study Completion Date

September 13, 2022

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

Adult differentiated autologous T-cells

After pretreatment, adult differentiated autologous T-cells with a chimeric antigen receptor with anti-CD19 specificity will be transfused.

Trial Locations (2)

08036

Hospital Clínic of Barcelona, Barcelona

08950

Hospital Sant Joan de Deu, Barcelona

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Sara V. Latorre

OTHER

NCT03144583 - Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy | Biotech Hunter | Biotech Hunter